Compounds › Combinations

GLOW

BPC-157 + TB-500 + GHK-Cu in one vial

Not approvedCombinations

AI-generated illustration. Not data, and not an image from a study.

Experimental material. Read before using anything from here.

Nothing on this page is a medical recommendation, prescription or treatment plan. It is an organized translation of protocols circulating in research communities and, where it exists, of what published trials tested. The two are marked differently — and they are not equivalent.

Most of the compounds here have no FDA approval for human use. Several are sold labeled "research use only", which means they have not gone through purity, sterility or dosage controls for human consumption. A community-reported dose is not a validated dose: it is what someone reported having done.

Talk to a licensed health professional before considering any of these compounds. If you already use one and feel anything unexpected, seek care — do not wait for the next routine test.

Summary

Research blend that puts three compounds in a single vial: BPC-157, TB-500 and GHK-Cu. The community groups the three because each hits a different part of how tissue repairs itself — local repair, cell migration and remodeling. It is KLOW without the KPV.

Quick reference

Reconstitution: Pre-mixed: 3.0 mL of bacteriostatic water → about 23.3 mg/mL of the total blend.
Schedule: Subcutaneous injection 1×/day for the pre-mixed product.
Measure: 10 units on a U-100 = 0.10 mL ≈ 2.33 mg of the total blend.
Status: Not approved. BPC-157 and TB-500 are banned by WADA for athletes.

Cycle Guidelines

Approach	Duration	Off period	Best for
Standard	4-6 weeks	2–4 weeks	Skin and general remodeling research
Extended	8–12 weeks	4–8 weeks	Complex recovery contexts
Skin-focused blend	4 weeks	2–4 weeks	Anti-aging-priority workflows

Choose Your Reconstitution Format

Metric	Value
Blend composition	50 mg GHK-Cu + 10 mg TB-500 + 10 mg BPC-157
BAC water added	3 mL
Total concentration	23.3 mg/mL total blend
Standard daily dose	0.10 mL (10 units) = ~2.33 mg total

Choose Your Reconstitution Format

Compound	Per-dose amount
GHK-Cu	~1.67 mg
TB-500	~0.33 mg
BPC-157	~0.33 mg

Choose Your Reconstitution Format

Vial	BAC water added	Concentration	250 mcg	500 mcg
5 mg	2 mL	2,500 mcg/mL	10 units (0.10 mL)	20 units (0.20 mL)
10 mg	2 mL	5,000 mcg/mL	5 units (0.05 mL)	10 units (0.10 mL)

Choose Your Reconstitution Format

Vial	BAC water added	Concentration	2.5 mg	5 mg
5 mg	1 mL	5 mg/mL	50 units (0.50 mL)	100 units (1.00 mL)
10 mg	2 mL	5 mg/mL	50 units (0.50 mL)	100 units (1.00 mL)

Choose Your Reconstitution Format

Vial	BAC water added	Concentration	1 mg	2 mg
50 mg	5 mL	10 mg/mL	10 units (0.10 mL)	20 units (0.20 mL)
100 mg	10 mL	10 mg/mL	10 units (0.10 mL)	20 units (0.20 mL)

GLOW Peptide Timeline & What to Monitor

Window	What People Often Report
Weeks 1-2	Inflammation-related changes; faster small-wound healing; fatigue during TB-500 loading.
Weeks 3-4	First skin-quality changes; firmer feel, slight texture improvement.
Weeks 5-8	Visible skin improvements driven by GHK-Cu; ongoing remodeling work.
Months 3+	Cumulative skin and connective-tissue changes with cycle continuation.

GLOW vs Wolverine vs KLOW vs Individual Peptides

Feature	GLOW	Wolverine	KLOW	Single Peptide
Compounds	BPC-157 + TB-500 + GHK-Cu	BPC-157 + TB-500	BPC-157 + TB-500 + GHK-Cu + KPV	Just one
Skin / anti-aging research	Strong (GHK-Cu)	Limited	Strong (GHK-Cu + KPV)	Varies (GHK-Cu standalone is closest)
Soft-tissue repair coverage	Strong	Strong	Strong	Compound-specific
Inflammation pathways	Multiple	Two pathways	Multiple + NF-kB (KPV)	One
Complexity	High	Moderate	High	Low
Cost	Highest	Moderate	Highest+	Lower

Storage and handling

The rules below apply to practically every lyophilized peptide in this reference. Where a compound has its own requirement, it appears in the table in the previous section.

Lyophilized powder, sealed: refrigerator, between 2 and 8 °C, protected from light. Many tolerate room temperature for short transport periods, but that is tolerance, not a recommendation.
After reconstitution: always refrigerated, between 2 and 8 °C. The stability window drops to days or a few weeks, depending on the compound.
Never freeze after reconstituting. The freeze–thaw cycle degrades the peptide.
Do not shake. Swirl the vial slowly. Shaking breaks the peptide chain.
Bacteriostatic water down the wall of the vial, in a slow stream, not squirted directly onto the powder.
Cloudy solution, with particles or a color change: discard. There is no recovery.

Lab tests and monitoring

This list is the one that appears recurrently in the source, with small variations by compound. It serves as a starting point for a conversation with a professional — not as a substitute for that conversation.

Before starting: complete blood count, comprehensive metabolic panel, lipid panel, fasting glucose and HbA1c, TSH and free T4, blood pressure and resting heart rate.
Depending on the compound: IGF-1 (GH axis), lipase and amylase (VIP and the incretin agonists), serum copper and ceruloplasmin (GHK-Cu and blends containing it), CRP.
Reassessment: most protocols review between week 4 and week 8, and then every 8–12 weeks.
Do not wait for the routine lab test in the face of abdominal pain, visual changes, a change in a mole, shortness of breath, asymmetric swelling or any new and persistent symptom. That is a reason to seek care, not a spreadsheet item.

Evidence limits

What these numbers are and what they are not. The values above were preserved exactly as they appear in the source, without reinterpretation. What the source describes as community practice is marked as such in the tables; what came from a published trial is too. A dose repeated by many people does not become a validated dose by repetition.

← Back to all compounds